Applied Drug Policy Research Experiences
Office of National Drug Control Policy
This opportunity closed September 6, 2026. 5 similar opportunities are open right now.
Similar opportunities open now
- Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Dec 2027
- Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Dec 2027
- Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)OpenNational Institutes of HealthCloses Jun 2028
- Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)OpenNational Institutes of HealthCloses Mar 2027
- Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Nov 2027Up to $300K
About this archived opportunity
This project will establish applied drug policy research experiences for graduate students and recent post-graduates to conduct rigorous research studies and data analyses to support the National Drug Control Strategy. This research will investigate dynamic shifts in, and associations between, illicit drug supply, drug use and their associated consequences, to help public health and public safety officials anticipate new drug outbreaks and prepare faster and more effective responses to protect the American public.
Historical details
- Status
- Closed
- Deadline
- September 6, 2026
- First captured
- August 7, 2026
- Publisher reference
- 363487
Free. One email, sent if this program reopens or Funding Landscape first discovers a close match that is currently open. We watch for 12 months, then stop. No list.